Texas Yale Capital Corp’s AngioDynamics ANGO Stock Holding History

Texas Yale Capital Corp’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-30,000	Closed	-$313K	–	409
2020 Q1	$313K	Hold	30,000	–	–	0.03%	319
2019 Q4	$480K	Hold	30,000	–	–	0.03%	332
2019 Q3	$553K	Hold	30,000	–	–	0.04%	313
2019 Q2	$591K	Sell	30,000 -30,000	-50%	-$611K	0.04%	302
2019 Q1	$1.37M	Buy	60,000 +30,000	+100%	+$651K	0.05%	277
2018 Q4	$604K	Hold	30,000	–	–	0.05%	272
2018 Q3	$652K	Hold	30,000	–	–	0.05%	295
2018 Q2	$667K	Hold	30,000	–	–	0.06%	276
2018 Q1	$518K	Buy	30,000 +9,914	+49%	+$165K	0.04%	318
2017 Q4	$334K	Buy	+20,086	New	+$343K	0.03%	376

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Texas Yale Capital Corp's ANGO Position: Q2 2020 in Review

Texas Yale Capital Corp sold out of AngioDynamics (ANGO) in Q2 2020, closing a stake of 30,000 shares — an estimated $313K sold.

Texas Yale Capital Corp first reported a position in ANGO in Q4 2017 and held it in 10 quarters. The position peaked at $1.37M in Q1 2019. 146 funds tracked by Wall St. Rank hold ANGO as of Q2 2020.

Texas Yale Capital Corp reported no remaining AngioDynamics position as of Q2 2020 after selling out during the quarter.
Texas Yale Capital Corp sold 30,000 AngioDynamics shares in Q2 2020, an estimated $313K.
Texas Yale Capital Corp first reported a position in AngioDynamics in Q4 2017 and held it in 10 quarters.
Texas Yale Capital Corp's AngioDynamics position peaked at $1.37M in Q1 2019.
146 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2020.

Based on Texas Yale Capital Corp's 13F filing for Q2 2020, filed 31 Jul 2020.